Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.2366 | 0.0927 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0111 | 0.602 | 0.9706 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0073 | 0.2366 | 0.0927 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0113 | 0.6202 | 0.5025 |
Echinococcus multilocularis | serotonin receptor | 0.0153 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0113 | 0.6202 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0153 | 1 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0073 | 0.2366 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.6202 | 0.5487 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0073 | 0.2366 | 0.0927 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0113 | 0.6202 | 1 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0113 | 0.6202 | 0.5025 |
Giardia lamblia | Hypothetical protein | 0.0067 | 0.1769 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0111 | 0.602 | 0.9706 |
Onchocerca volvulus | 0.0113 | 0.6202 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.602 | 0.527 |
Loa Loa (eye worm) | serotonin transporter b | 0.0073 | 0.2366 | 0.0927 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0153 | 1 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0073 | 0.2366 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.2366 | 0.0927 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0113 | 0.6202 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0067 | 0.1769 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0067 | 0.1769 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0113 | 0.6202 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.2366 | 0.0927 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0111 | 0.602 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0111 | 0.602 | 0.9706 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0067 | 0.1769 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0067 | 0.1769 | 0.5 |
Echinococcus granulosus | 6 phosphofructo 2 kinase:fructose 2 | 0.0113 | 0.6202 | 0.5025 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.4 nM | Inhibition of 8-OH DPAT binding to rat hydroxytryptamine 1A receptor expresssed in CHO cells | ChEMBL. | 15341484 |
IC50 (binding) | = 0.4 nM | Inhibition of 8-OH DPAT binding to rat hydroxytryptamine 1A receptor expresssed in CHO cells | ChEMBL. | 15341484 |
IC50 (binding) | = 5 nM | Inhibition of [3H]-5-HT re-uptake in rat synaptosomes | ChEMBL. | 15341484 |
IC50 (binding) | = 5 nM | Inhibition of [3H]-5-HT re-uptake in rat synaptosomes | ChEMBL. | 15341484 |
IC50 (binding) | = 9.4 nM | Displacement of [3H]-spiperone from dopamine D2 receptor of rat striatal membranes | ChEMBL. | 15341484 |
IC50 (binding) | = 9.4 nM | Displacement of [3H]-spiperone from dopamine D2 receptor of rat striatal membranes | ChEMBL. | 15341484 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.